InvestorsHub Logo
icon url

soupertrooper

02/22/20 5:07 PM

#247565 RE: IgnoranceIsBliss #247564

Well, I guess “I can live” with that scenario. Only downside is that I’m gonna miss ya, Tasty. Really.
icon url

rosemountbomber

02/22/20 5:25 PM

#247567 RE: IgnoranceIsBliss #247564

TTE, do the CVRs really complicate the tax reporting? I got CVRs with the BMY-Celgene deal but that was in my tax sheltered account so no concern. I have Amarin shares in both tax sheltered and taxable accounts.
icon url

oneragman

02/22/20 6:02 PM

#247570 RE: IgnoranceIsBliss #247564

Tasty, I came to the same conclusion about a month or two ago. I would prefer a year or two of GIA, but cannot ignore how this is playing out. Talk about slow walking. I too believe that it's about the patent trial. I have mentioned before that James Murphy at the shareholders meeting was told by a board member that 2nd quarter 2020 was when things would happen. This was mentioned at a time when we thought we could be approved in August or September eliminating any concerns about making 2020 formularies with a CVD indication. The board member statement made no sense in that context unless you had a different plan in place involving a 3rd party. The patents are the key as they were already expected to go to court 1st quarter 2020. It's the most logical answer to how this has played out. Assuming the case ends with an AMRN win, it would be a great time to go big.
icon url

Lemmiwinks

02/22/20 6:17 PM

#247571 RE: IgnoranceIsBliss #247564

I’ll get he/she/they a lap dance and some Johnny Blue....that should appease the biobillionair for a time.
HARD not to be happy with that....I miss him ranting about woodCOCK!
Lem-
icon url

Markipeach

02/22/20 7:33 PM

#247583 RE: IgnoranceIsBliss #247564

It will happen sooner or later. AMRN cant GIA